Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Food and Drug Administration (FDA) on December 1, 2021. About IGC: India Globalization Capital, Inc.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology. See the Answer.

Epilepsy 52

Epilepsy Therapy Extraction Data 52

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

DECEMBER 2, 2021

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. THC is a naturally occurring cannabinoid produced by the cannabis plant. million individuals in the U.S.

Clinical Trials 52

Clinical Trials Data Patients THC 52

The Joint Blog

FEBRUARY 27, 2019

Cannabinoids “may be an effective adjunct for the treatment of pancreatic cancer”, according to a new study. The study, titled Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer, was published by the Journal of Pancreatic Cancer, and has been epublished by the National Institute of Health.

Treatment 46

Treatment Cannabinoids Patients Therapy 46

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

TheAnswerPage

JANUARY 11, 2022

and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ In addition, if clinicians are not well informed about the health effects of cannabinoid-based products, clinicians will not be able to optimally treat their patients. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Veriheal

MAY 26, 2022

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

JUNE 30, 2023

Researchers say this emphasizes just how important it is that psilocybin therapy be done in a controlled setting with therapy and community-based after-care. The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Veriheal

JANUARY 26, 2023

Further exploration of this possibility is underway to provide better care and more effective therapies for individuals living with the condition. Thus, this groundbreaking study laid the foundation for understanding how cannabinoids can support mental health.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Veriheal

OCTOBER 29, 2020

Of that, the American National Institute on Drug Abuse (NIDA) has invested just over $1 billion and has allocated far more money to researching cannabis misuse and the negative effects of consuming cannabis and its compounds as a form of therapy. The data for this graphic was provided by Jim Hudson at Hellth.com. . Canada, and the U.K)

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

The Joint Blog

MARCH 3, 2021

The study found “significant improvements were observed” following the initiation of cannabis therapy in most patients. The study concludes by stating that “The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment.

Therapy 61

Therapy Hybrid Marijuana Research and Development 61

Cannabis Law Report

JULY 8, 2021

Seeks To Identify Novel Cannabinoids For Therapeutic Use. The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. CHARLOTTE, N.C.–(BUSINESS

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. We could potentially develop north of 11,000 drugs that are cannabinoid-based. This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. These medications are combined in what’s known as HAART (highly active antiretroviral therapy). What is HIV and how is it manifested? 2016 ( 3 ).

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

CannaMD

OCTOBER 29, 2020

On the contrary, after analyzing cross-sectional data from two population-based surveys including over 50,000 respondents, the American Journal of Epidemiology reports: The proportion of obese participants decreased with the frequency of cannabis use. Cannabis: 2. What’s scarier than a Halloween mask? Cannabis: 3. Shaking with fear!

Research and Development 92

Research and Development Blood Pressure Data Clinical Trials 92

The Cannigma

FEBRUARY 2, 2021

Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. The study, led by the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics , found anxiety was among the top three reasons for a medicinal cannabis prescription. Medicinal cannabis has been so effective I don’t even think about other therapies,” Rocky said.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

NOVEMBER 3, 2021

The Company continues to focus on medical training for healthcare professionals after receiving full Continuing Professional Development (“CPD”) accreditation for its digital educational platform, Khiron Academy, and brings its proprietary clinical data generated in LatAm to the UK.

Therapy 52

Therapy Access Patients Treatment 52

Cannabis Law Report

DECEMBER 1, 2019

Suffering from refractory epilepsy, the girl failed to respond to therapies and had exhausted all currently registered medications for treatment, the Ministry of Home Affairs (MHA) told The Sunday Times. Results from the studies cannot be extrapolated to other cannabinoid medications, he added.

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines. For more information, visit www.inmedpharma.com.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

SEPTEMBER 21, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has published its latest paper in the medical journal Frontiers in Psychiatry , examining the benefits of medicinal cannabis products for individuals with anxiety and depression. About Realm of Caring.

CBD 52

CBD Data Therapy Sleep 52

Cannabis Law Report

DECEMBER 16, 2019

Emerald Clinics captures clinical data from patients to generate evidence for the safety and efficacy of cannabis medicines. Emerald Clinics operates a network of four medical clinics around Australia, focused on providing care for patients who have exhausted conventional therapies and might be suitable for cannabinoid-based medicines.

Medicine 59

Medicine Data Safety Therapy 59

The Cannigma

JULY 17, 2022

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry.

Advocacy 120

Advocacy Education Events Epilepsy 120

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. Securities and Exchange Commission (“SEC”) on July 13, 2020. About IGC: India Globalization Capital, Inc.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Veriheal

MARCH 3, 2022

The report titled “ Cannabis, Cannabinoids, and Sleep: a Review of the Literature ,” also revealed that delta-9 tetrahydrocannabinol (THC) may reduce sleep latency. Cannabis, Cannabinoids, and Sleep: What Did the Study Find? Cannabinoids and Sleep: An Area for Further Study. adults between the ages of 20-59.

Sleep 88

Sleep Consumption Cannabinoids Cannabis 88

Marijuanally

SEPTEMBER 5, 2018

A cross-sectional analysis of data from the US National Health and Nutrition Examination Survey ( NHANES ) between 2005 and 2010 shows that present or previous marijuana users were less likely to experience type 2 diabetes compared to non-marijuana users. Medical Marijuana versus diabetes. SEE RELATED ARTICLE Marijuana Questions And Answers.

THC 75

THC Cannabinoids Therapy CBD 75

Cannabis Law Report

SEPTEMBER 15, 2021

Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. Some concerns include variability in product formulations and product labeling, other cannabinoid and terpene content, and variable delta-8 THC concentrations. synthetic conversion).

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

MAY 29, 2022

FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. More recently, MDMA therapy has inched closer to FDA approval. 10] In the meantime, FDA has approved some requests for compassionate use. [11].

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Healer

MARCH 26, 2021

For years, Tim Gresh took dozens of prescription opioid medications per day, seeking any relief for the debilitating back pain that he – no matter which medication or therapy he used – could just not shake. . “It THC is the main psychoactive compound in marijuana, while CBD is a non-intoxicating cannabinoid found in the cannabis plant.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Healer

APRIL 9, 2019

Cannabinoids can modulate bone remodeling, often promoting bone growth and inhibiting bone resorption, and some are currently being studied for prevention and treatment of osteoporosis. Our bodies increase the number of cannabinoid receptors present in tissues that are injured or inflamed, indicating a role for cannabinoids in healing.

Research and Development 52

Research and Development Cannabinoids Data CBD 52

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. Prevalence and incidence of rare diseases: Bibliographic data.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

SpeedWeed

MARCH 13, 2021

“Preclinical evidence suggests that cannabinoids could be widely beneficial to neurodegenerative diseases, including PD.”. As a result, many PD patients now have legal access to cannabis as an alternative or complementary therapy. After analyzing the data, the researchers found that 24.5%

Patients 52

Patients Treatment Therapy Sleep 52